Prelude Therapeutics Inc
PRLD- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001678660
No open-market purchases or sales by Prelude Therapeutics Inc insiders were filed in the last 90 days; 75 institutions reported holding it in 13F filings for Q2 2026, worth $264.3M in total; no superinvestor holds it.
Q1 2024 vs. Q4 2023
How the institutions holding Prelude Therapeutics Inc changed between Q4 2023 and Q1 2024.
All holders in Q1 2024All holders in Q4 2023
| Measure | Q4 2023 | Q1 2024 | Change |
|---|---|---|---|
| Holders | 56 | 58 | +2 |
| Shares | 34.7M | 34.2M | −513.1K (−1.5%) |
| Value | $148.3M | $162.1M | +$13.9M (+9.4%) |
New holders (7)
Institutions that held Prelude Therapeutics Inc at the end of Q1 2024 but not at the end of Q4 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Cerity Partners LLC | 32,500 | $154.1K | 0.00% |
| Kennedy Capital Management, Inc. | 25,035 | $118.7K | 0.00% |
| Connor, Clark & Lunn Investment Management Ltd. | 20,066 | $95.1K | 0.00% |
| Zacks Investment Management | 18,457 | $87.5K | 0.00% |
| Walleye Capital LLC | 16,380 | $77.6K | 0.00% |
| Nelson, Van Denburg & Campbell Wealth Management Group, LLC | 1 | $4 | 0.00% |
| CWM, LLC | 2 | $0 | 0.00% |
Sold out (5)
Institutions that held Prelude Therapeutics Inc at the end of Q4 2023 and filed for Q1 2024 without it.
| Institution | Shares, Q4 2023 | Value, Q4 2023 |
|---|---|---|
| Jacobs Levy Equity Management, Inc | 131,307 | $560.7K |
| Squarepoint Ops LLC | 29,418 | $125.6K |
| Virtu Financial LLC | 13,607 | $58.0K |
| SG Americas Securities, LLC | 13,100 | $56.0K |
| Simplex Trading, LLC | 67 | $0 |